ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis

Liu, Chao; Wang, Kai; Li, Luyuan; Lv, Qingquan; Liu, Yumei; Hu, Tian; Trent, Jonathan C.*; Sun, Bing*; Hu, Qinyong*南方医科大学; 山东省医学科学院; 武汉大学; 5
American Journal of Cancer Research2021DOI: 10.7150/jca.54205
5被引8阅读
引用收藏
分享

摘要

Purpose: Data are extremely limited with regards to the impact of COVID-19 on cancer patients. Our study explored the distinct clinical features of COVID-19 patients with cancer. @@@ Experimental Design: 189 COVID-19 patients, including 16 cancer patients and 173 patients without cancer, were recruited. Propensity score 1:4 matching (PSM) was performed between cancer patients and patients without cancer based on age, gender and comorbidities. Survival was calculated by the Kaplan-Meier method and the difference was compared by the log-rank test. @@@ Results: PSM analysis yielded 16 cancer patients and 64 propensity score-matched patients without cancer. Compared to patients without cancer, cancer patients tended to have leukopenia and elevated high-sensitivity C-reactive protein (hs-CRP) and procalcitonin. For those with critical COVID-19, cancer patients had an inferior survival than those without cancer. Also, cancer patients with severe/critical COVID-19 tended to be male and present with low SPO2 and albumin, and high hs-CRP, lactate dehydrogenase and blood urea nitrogen on admission compared to those with mild COVID-19. In terms of risk factors, recent cancer diagnosis (within 1 year of onset of COVID-19) and anti-tumor treatment within 3 months of COVID-19 diagnosis were associated with inferior survival. @@@ Conclusions: We found COVID-19 patients with cancer have distinct clinical features as compared to patients without cancer. Importantly, cancer patients with critical COVID-19 were found to have poorer outcomes compared to those without cancer. In the cancer cohort, patients with severe/critical COVID-19 presented with a distinct clinical profile from those with mild COVID-19; short cancer history and recent anti-cancer treatment were associated with inferior survival.

学科与关键词

关键词
COVID-19clinical characteristicssurvivalpropensity score matchingcancer
相关
加载中…
  • Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort study
    Akingboye, Akinfemi; Mahmood, Fahad; Amiruddin, Nabeel; Reay, Michael; Nightingale, Peter; Ogunwobi, Olorunseun O.*BMJ Open, 2021, 11(12): e053352.被引 2
  • Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions
    Peng, Ying-Long; Wang, Zi-Yan; Zhong, Ri-Wei; Mei, Shi-Qi; Liu, Jia-Qi; Tang, Li-Bo; Guo, Zhi; Ren, Zi-Rui; Wu, Lv; Deng, Yu; Chen, Zhi-Hong; Zhou, Qing; Xu, Chong-Rui*Cancers, 2024, 16(2): 304.
  • High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
    Wang, Qianqian; Li, Liangyu; Qu, Tianyu; Li, Jie; Wu, Lingxiang; Li, Kening; Wang, Ziyu; Zhu, Mengyan; Huang, Bin; Wu, Wei; Wu, Min; Ding, Rong; Zhang, Zhihong; Wang, Qianghu; Xia, Xinyi*; Li, Pengping*; Zhang, Zhi; Guo, Renhua*Frontiers in Oncology, 2021, 11: 644575.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
American Journal of Cancer Research
发表日期
2021
卷期
第 12 卷, 第 12 期
页码
3558-3565
DOI
10.7150/jca.54205
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81670144]

作者

  • L

    Liu, Chao (第一作者)

    wuhan univ · shandong acad med sci

  • W

    Wang, Kai

    southern med univ

查看全部 9 位作者收起作者
  • L

    Li, Luyuan

  • L

    Lv, Qingquan

  • L

    Liu, Yumei

  • H

    Hu, Tian

  • T

    Trent, Jonathan C. (通讯)

    14

  • S

    Sun, Bing (通讯)

    5 · chinese peoples liberat army gen hosp

  • H

    Hu, Qinyong (通讯)

    wuhan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417